Literature DB >> 25613966

Essential medicines for children.

Kalle Hoppu1, Shalini Sri Ranganathan2.   

Abstract

Millions of children die every year before they reach the age of 5 years, of conditions largely treatable with existing medicines. The WHO Model List of Essential Medicines was launched in 1977 to make the most necessary drugs available to populations whose basic health needs could not be met by the existing supply system. During the first 30 years of the Model List of Essential Medicines, children's needs were not systematically considered. After adoption of the 'Better medicines for children' resolution by the World Health Assembly, things changed. The first WHO Model List of Essential Medicines for Children was drawn up by a Paediatric Expert Subcommittee and adopted in October 2007. The most recent, 4th Model List of Essential Medicines for Children was adopted in 2013. Data from country surveys show that access to essential medicines for children is still generally poor; much more work is needed. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Health Service; Pharmacology; Therapeutics

Mesh:

Substances:

Year:  2015        PMID: 25613966     DOI: 10.1136/archdischild-2013-305705

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  1 in total

1.  Approval status and evidence for WHO essential medicines for children in the United States, United Kingdom, and Japan: a cross-sectional study.

Authors:  Rumiko Shimazawa; Masayuki Ikeda
Journal:  J Pharm Policy Pract       Date:  2017-01-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.